These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 12397753

  • 1. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
    Kishima Y, Yoshida K, Enomoto H, Yamamoto M, Kuroda T, Okuda Y, Uyama H, Nakamura H.
    Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase C inhibitor, H-7 suppresses the growth activity of hepatoma-derived growth factor.
    Kambe H, Kishima Y, Kuroda T, Enomoto H, Ogawa H, Nakmaura H.
    Hepatogastroenterology; 2000; 47(36):1645-8. PubMed ID: 11149024
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
    Gong ZB, Liu JM, Li YM.
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
    [Abstract] [Full Text] [Related]

  • 4. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, Changchien CS, Lee CM, Chuang JH, Tai MH.
    Cancer; 2003 Oct 01; 98(7):1444-56. PubMed ID: 14508832
    [Abstract] [Full Text] [Related]

  • 5. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
    Alexia C, Lasfer M, Groyer A.
    Ann N Y Acad Sci; 2004 Dec 01; 1030():219-29. PubMed ID: 15659801
    [Abstract] [Full Text] [Related]

  • 6. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.
    Enomoto H, Yoshida K, Kishima Y, Kinoshita T, Yamamoto M, Everett AD, Miyajima A, Nakamura H.
    Hepatology; 2002 Dec 01; 36(6):1519-27. PubMed ID: 12447878
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells.
    Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT.
    Apoptosis; 2008 Sep 01; 13(9):1135-47. PubMed ID: 18651222
    [Abstract] [Full Text] [Related]

  • 10. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2003 Sep 01; 23(3):577-83. PubMed ID: 12888890
    [Abstract] [Full Text] [Related]

  • 11. Antisense oligonucleotides: inhibition of liver cell proliferation and in vivo disposition.
    Inagaki M, Togawa K, Carr BI, Ghosh K, Cohen JS.
    Transplant Proc; 1992 Dec 01; 24(6):2971-2. PubMed ID: 1334602
    [Abstract] [Full Text] [Related]

  • 12. [Enhancing effect of antisense oligonucleotide targeting bFGF on apoptosis in hepatoma cells in vitro].
    Qi JL, Wu N, Zhou DF, Bu B, Zhang H, Zhang XQ, Liu ZF, Ren GH.
    Zhonghua Zhong Liu Za Zhi; 2008 Feb 01; 30(2):103-6. PubMed ID: 18646690
    [Abstract] [Full Text] [Related]

  • 13. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D, Ishikawa H, Matsumoto K, Shibata H, Motoyoshi Y, Fukuta M, Kawashimo H, Goto T, Taura N, Ichikawa T, Hamasaki K, Nakao K, Umezawa K, Eguchi K.
    Int J Oncol; 2006 Sep 01; 29(3):713-9. PubMed ID: 16865289
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
    Levy Y, Tsapis A, Brouet JC.
    J Clin Invest; 1991 Aug 01; 88(2):696-9. PubMed ID: 1864979
    [Abstract] [Full Text] [Related]

  • 15. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.
    Takei Y, Kadomatsu K, Matsuo S, Itoh H, Nakazawa K, Kubota S, Muramatsu T.
    Cancer Res; 2001 Dec 01; 61(23):8486-91. PubMed ID: 11731432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
    Burch RM, Mahan LC.
    J Clin Invest; 1991 Oct 01; 88(4):1190-6. PubMed ID: 1833422
    [Abstract] [Full Text] [Related]

  • 19. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C, Pastorino F, Marimpietri D, Pagnan G, Pistorio A, Allen TM, Pistoia V, Ponzoni M.
    J Natl Cancer Inst; 2004 Aug 04; 96(15):1171-80. PubMed ID: 15292389
    [Abstract] [Full Text] [Related]

  • 20. Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.
    Ying TH, Hsieh YH, Hsieh YS, Liu JY.
    Cell Biol Int; 2008 Feb 04; 32(2):210-6. PubMed ID: 17950002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.